Psychological and socioeconomic factors associated with depression and anxiety among patients with psoriasis

Abstract Patients with psoriasis have an increased prevalence of depression and anxiety compared to the general population. Previous studies linked sex, age and psoriasis severity to depression and/or anxiety (DA), but research on factors like psoriasis visibility, stress, socioeconomic status and social support is limited. This study explored factors associated with moderate-to-severe DA in patients with psoriasis, assessing both well-known patient characteristics (sex, age and disease severity) and psychological and socioeconomic factors. A web-based survey among psoriasis patients was conducted. The Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) were used to assess symptoms of depression and anxiety respectively. Multivariable logistic regression analyses were used to assess associations between moderate-to-severe DA and possible contributing factors. Of 267 patients, 54 (20.2%) screened positive for symptoms of depression (PHQ-9 ≥ 10) and/or symptoms of anxiety (GAD-7 ≥ 10). Stress (OR 23.34, 95%CI = 3.01-181.21), low income (OR 2.90, 95%CI = 1.14–7.35), and low education level (OR 2.32, 95%CI = 1.04–5.15) were associated with DA, while sex (OR 1.40, 95%CI = 0.60–3.26), age (OR 0.82, 95%CI = 0.65–1.05) and psoriasis severity (OR 1.98, 95%CI = 0.97–4.03) were not significantly associated. Sensitivity analysis showed association of low perceived social support (OR 11.30, 95%CI = 4.02–31.79), psoriasis severity (OR 2.25, 95%CI = 1.01–4.97), and age (OR 0.71, 95%CI = 0.54–0.93) with DA. Stress and low perceived social support were strongly associated with moderate-to-severe DA in patients with psoriasis. Less strong associations were found for low income, low education level, psoriasis severity, and age. This emphasizes the need for additional support beyond the medical domain to address the mental health of patients with psoriasis.

Authors

Institutions

Publication Details

Journal
Archives of Dermatological Research
Published
2026-08-21
DOI
https://doi.org/10.1007/s00403-026-04843-w
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psychological and socioeconomic factors associated with depression and anxiety among patients with psoriasis

Marieke M.B. Seyger, E.M.G.J. de Jong, Malak Al‐Gawahiri, Linda T.H. Godding et al.
Archives of Dermatological Research
Psoriasis: Treatment and Pathogenesis
article

Psychological and socioeconomic factors associated with depression and anxiety among patients with psoriasis

Marieke M.B. Seyger, E.M.G.J. de Jong, Malak Al‐Gawahiri, Linda T.H. Godding, J.M.P.A. van den Reek, Veronica R. Janssen, Donna R. Limbeek
article en

Abstract

Abstract Patients with psoriasis have an increased prevalence of depression and anxiety compared to the general population. Previous studies linked sex, age and psoriasis severity to depression and/or anxiety (DA), but research on factors like psoriasis visibility, stress, socioeconomic status and social support is limited. This study explored factors associated with moderate-to-severe DA in patients with psoriasis, assessing both well-known patient characteristics (sex, age and disease severity) and psychological and socioeconomic factors. A web-based survey among psoriasis patients was conducted. The Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder scale (GAD-7) were used to assess symptoms of depression and anxiety respectively. Multivariable logistic regression analyses were used to assess associations between moderate-to-severe DA and possible contributing factors. Of 267 patients, 54 (20.2%) screened positive for symptoms of depression (PHQ-9 ≥ 10) and/or symptoms of anxiety (GAD-7 ≥ 10). Stress (OR 23.34, 95%CI = 3.01-181.21), low income (OR 2.90, 95%CI = 1.14–7.35), and low education level (OR 2.32, 95%CI = 1.04–5.15) were associated with DA, while sex (OR 1.40, 95%CI = 0.60–3.26), age (OR 0.82, 95%CI = 0.65–1.05) and psoriasis severity (OR 1.98, 95%CI = 0.97–4.03) were not significantly associated. Sensitivity analysis showed association of low perceived social support (OR 11.30, 95%CI = 4.02–31.79), psoriasis severity (OR 2.25, 95%CI = 1.01–4.97), and age (OR 0.71, 95%CI = 0.54–0.93) with DA. Stress and low perceived social support were strongly associated with moderate-to-severe DA in patients with psoriasis. Less strong associations were found for low income, low education level, psoriasis severity, and age. This emphasizes the need for additional support beyond the medical domain to address the mental health of patients with psoriasis.

Archives of Dermatological ResearchVol. 318(1)
Radboud University Nijmegen (NL), Leiden University Medical Center (NL), Radboud University Medical Center (NL), Radboud Institute for Molecular Life Sciences (NL)
Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Celgene, Radboud Universiteit, Radboud Universitair Medisch Centrum, LEO Pharma
No poverty
Openalex Percentile: Top 16%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.